PMC:7600245 / 57637-57797
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T251 | 60-68 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T581 | 32-38 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T76776 | 13-22 | Chemical | denotes | sirolimus | http://purl.obolibrary.org/obo/CHEBI_9168 |
T11986 | 114-132 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T434 | 0-160 | Sentence | denotes | Accordingly, sirolimus is being tested for the treatment of COVID-19 patients either alone or in combination with hydroxychloroquine in several clinical trials. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1777 | 69-77 | Species | denotes | patients | Tax:9606 |
1784 | 13-22 | Chemical | denotes | sirolimus | MESH:D020123 |
1785 | 114-132 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
1792 | 60-68 | Disease | denotes | COVID-19 | MESH:C000657245 |